An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Dec 02 2016President-elect Trump chooses a retired Marine general to head the Pentagon. Syrian rebels agree to form a new alliance as the regime bombards Aleppo. And thousands of Cubans turn out to watch Fidel Castro's funeral procession. A panel of journalists joins Diane for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Dec 02 2016President-elect Donald Trump starts a victory tour with a stop in Cincinnati. Nancy Pelosi is re-elected House minority leader. And North Carolina prosecutors say the police officer who killed Keith Lamont Scott will not face charges.

President-Elect Trump And U.S. Trade

Thursday, Dec 01 2016During the campaign President-elect Donald Trump promised to bring jobs back to the U.S. by changing the rules with our global trading partners: What stronger protectionist policies could mean for American workers and the U.S. economy.